Sign inJoin waitlistJoin the waitlist

BO

Beth Overmoyer

Physician · Dana-Farber Cancer Institute

Credentials: · · ·

History

Dana-Farber Cancer Institute
2019–Present

Hematology and Medical Oncology
1989–1992
Internal Medicine
1986–1989
Case Western Reserve Univ Sch of Med
1982–1986

Research

Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer
Journal of Clinical Oncology · 2005 · 1,039 citations
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer
New England Journal of Medicine · 2015 · 577 citations
Phase I safety, pharmacokinetics, and clinical activity study of lapatinib (GW572016), a reversible dual inhibitor of epidermal growth factor receptor tyrosine kinases, in heavily…
Journal of Clinical Oncology · 2005 · 500 citations

Eric Winer
30 papers
Sara Tolaney
26 papers
JB
Jennifer Bellon
22 papers
Faina Nakhlis
21 papers
Filipa Lynce
16 papers
Nancy Lin
15 papers
EY
Eren Yeh
13 papers
BH
Beth Harrison
12 papers
Heather Jacene
12 papers
IK
Ian Krop
12 papers
Laura Warren
12 papers · 3 as a resident
Hope Rugo
10 papers